New Results
Sensitivity to gains during risky decision-making differentiates chronic cocaine users from stimulant-naïve controls
B. Kluwe-Schiavon, A. Kexel, G. Manenti, D.M. Cole, M.R. Baumgartner, R. Grassi-Oliveira, P.N. Tobler, B.B. Quednow
doi: https://doi.org/10.1101/795443
B. Kluwe-Schiavon
Experimental and Clinical Pharmacopsychology; Department of Psychiatry, Psychotherapy, and Psychosomatics; Psychiatric Hospital, University of Zurich; Switzerland
A. Kexel
Experimental and Clinical Pharmacopsychology; Department of Psychiatry, Psychotherapy, and Psychosomatics; Psychiatric Hospital, University of Zurich; Switzerland
G. Manenti
Experimental and Clinical Pharmacopsychology; Department of Psychiatry, Psychotherapy, and Psychosomatics; Psychiatric Hospital, University of Zurich; SwitzerlandNeural Circuits and Cognition Lab, European Neuroscience Institute Göttingen, University Medical Center Göttingen and Max-Planck-Society, Germany
D.M. Cole
Experimental and Clinical Pharmacopsychology; Department of Psychiatry, Psychotherapy, and Psychosomatics; Psychiatric Hospital, University of Zurich; Switzerland
M.R. Baumgartner
Center of Forensic Hairanalytics, Institute of Forensic Medicine, University of Zurich, Switzerland
R. Grassi-Oliveira
Developmental Cognitive Neuroscience Laboratory; Brain Institute; Pontifical Catholic University of Rio Grande do Sul; Brazil
P.N. Tobler
Zurich Center for Neuroeconomics, Department of Economics, University of Zürich, SwitzerlandNeuroscience Center Zurich, University of Zurich and Swiss Federal Institute of Technology Zurich, Switzerland
B.B. Quednow
Experimental and Clinical Pharmacopsychology; Department of Psychiatry, Psychotherapy, and Psychosomatics; Psychiatric Hospital, University of Zurich; SwitzerlandNeuroscience Center Zurich, University of Zurich and Swiss Federal Institute of Technology Zurich, Switzerland

Article usage
Posted October 07, 2019.
Sensitivity to gains during risky decision-making differentiates chronic cocaine users from stimulant-naïve controls
B. Kluwe-Schiavon, A. Kexel, G. Manenti, D.M. Cole, M.R. Baumgartner, R. Grassi-Oliveira, P.N. Tobler, B.B. Quednow
bioRxiv 795443; doi: https://doi.org/10.1101/795443
Subject Area
Subject Areas
- Biochemistry (2502)
- Bioengineering (1759)
- Bioinformatics (9734)
- Biophysics (3930)
- Cancer Biology (2996)
- Cell Biology (4237)
- Clinical Trials (135)
- Developmental Biology (2655)
- Ecology (4133)
- Epidemiology (2033)
- Evolutionary Biology (6936)
- Genetics (5247)
- Genomics (6534)
- Immunology (2209)
- Microbiology (7019)
- Molecular Biology (2786)
- Neuroscience (17431)
- Paleontology (127)
- Pathology (433)
- Physiology (1069)
- Plant Biology (2516)
- Synthetic Biology (836)
- Systems Biology (2700)
- Zoology (439)